{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:53:53Z","timestamp":1785887633751,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Obesity represents a major global health challenge, yet its prevalence and clinical significance may vary substantially depending on the definition applied. While the Body Mass Index (BMI) remains the most widely used indicator, alternative frameworks such as the European Association for the Study of Obesity (EASO) classification, the metabolically healthy obesity (MHO) concept, and the recent Lancet functional framework offer broader, clinically oriented perspectives. We conducted a cross-sectional, population-based analysis of 108,350 adults. BMI was calculated from measured height and weight, with overweight defined as 25.0\u201329.9\u00a0kg\/m\u00b2 and obesity as \u2265\u200930.0\u00a0kg\/m\u00b2. EASO obesity classification incorporated both BMI and the presence of obesity-related complications. Metabolic health was assessed using established cut-offs for hypertension, diabetes, and dyslipidaemia, and MHO was defined as BMI\u2009\u2265\u200930.0\u00a0kg\/m\u00b2 without metabolic abnormalities. By conventional BMI cut-offs 77,393 participants were overweight or obese, within which 47.2% were obese and 52.8% were overweight, respectively. In contrast, the EASO classification identified 29,044 respondents of the total population as obese in the overweight strata, leaving only 11,815 as non-obese. Therefore, among individuals with BMI 25.0\u201329.9, 71.1% were classified as obese by EASO criteria. Among participants with BMI-defined obesity, 12,151 (35.0%) were metabolically healthy obese and 22,585 (65.0%) were considered metabolically unhealthy. In terms of comorbidities, 82.8% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200924,521) of obese were clinically obese and 17.2% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20095,094) were pre-clinical obese. Obesity prevalence and the identification of metabolically healthy subgroups depend on the definition applied. While BMI alone provides a conservative estimate, other frameworks capture a much broader population. These findings highlight the need for unified definitions that may better reflect clinical risk and guide both public health surveillance and individual patient management.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-53073-7","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T20:32:25Z","timestamp":1779827545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing multiple definitions of obesity in a large nationwide health program"],"prefix":"10.1038","volume":"16","author":[{"given":"Gerg\u0151 J\u00f3zsef","family":"Sz\u0151ll\u0151si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Csenteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Andr\u00e9ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Andr\u00e9ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Jancs\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Vajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"21","key":"53073_CR1","doi-asserted-by":"publisher","first-page":"E984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley, T. M. et al. Obesity and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 143(21), E984\u2013E1010 (2021).","journal-title":"Circulation"},{"key":"53073_CR2","unstructured":"World Obesity Federation. Global Obesity Observatory [Internet]. Hungary. [cited 2025 Nov 17]. Available from: https:\/\/data.worldobesity.org\/country\/hungary-93\/"},{"key":"53073_CR3","unstructured":"World Health Organization. Obesity and overweight [Internet]. [cited 2025 Nov 17]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"key":"53073_CR4","unstructured":"National Academies of Sciences, Engineering, and Medicine & Board on F and N; Solutions Research on Obesity. ; Callahan EA, editor. The Science, Strengths, and Limitations of Body Mass Index. In: Translating Knowledge of Foundational Drivers of Obesity into Practice: Proceedings of a Workshop Series [Internet]. Washington (DC): National Academies Press (US); [cited 2025 Nov 17]. (2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594362\/"},{"issue":"578","key":"53073_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3399\/bjgp10X515548","volume":"60","author":"S Humphreys","year":"2010","unstructured":"Humphreys, S. The unethical use of BMI in contemporary general practice. Br. J. Gen. Pract. 60 (578), 696\u2013697 (2010).","journal-title":"Br. J. Gen. Pract."},{"issue":"1","key":"53073_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12966-025-01719-6","volume":"22","author":"C Byker Shanks","year":"2025","unstructured":"Byker Shanks, C., Bruening, M. & Yaroch, A. L. BMI or not to BMI? Debating the value of body mass index as a measure of health in adults. Int. J. Behav. Nutr. Phys. Act. 22 (1), 23 (2025).","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"53073_CR7","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1038\/s41598-023-30527-w","volume":"13","author":"SM Jeong","year":"2023","unstructured":"Jeong, S. M., Lee, D. H., Rezende, L. F. M. & Giovannucci, E. L. Different correlation of body mass index with body fatness and obesity-related biomarker according to age, sex and race-ethnicity. Sci. Rep. 13, 3472 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"53073_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0899-9007(00)00471-8","volume":"17","author":"DC Frankenfield","year":"2001","unstructured":"Frankenfield, D. C., Rowe, W. A., Cooney, R. N., Smith, J. S. & Becker, D. Limits of body mass index to detect obesity and predict body composition. Nutrition 17 (1), 26\u201330 (2001).","journal-title":"Nutrition"},{"key":"53073_CR9","unstructured":"European Association for the Study of Obesity. A new framework for the diagnosis, staging and management of obesity in adults [Internet]. 2024 [cited 2025 Nov 17]. Available from: https:\/\/easo.org\/a-new-framework-for-the-diagnosis-staging-and-management-of-obesity-in-adults\/"},{"issue":"3","key":"53073_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino, F. et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 13 (3), 221\u2013262 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"53073_CR11","doi-asserted-by":"publisher","first-page":"bnaa004","DOI":"10.1210\/endrev\/bnaa004","volume":"41","author":"M Bl\u00fcher","year":"2020","unstructured":"Bl\u00fcher, M. Metabolically Healthy Obesity. Endocr. Rev. 41 (3), bnaa004 (2020).","journal-title":"Endocr. Rev."},{"issue":"5","key":"53073_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bl\u00fcher","year":"2019","unstructured":"Bl\u00fcher, M. Obesity: Global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15(5), 288\u2013298 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9669","key":"53073_CR13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"Prospective Studies Collaboration","year":"2009","unstructured":"Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900\u2008000 adults: collaborative analyses of 57 prospective studies. Lancet 373 (9669), 1083\u20131096 (2009).","journal-title":"Lancet"},{"issue":"11","key":"53073_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/ejcn.2017.103","volume":"71","author":"S Vallg\u00e5rda","year":"2017","unstructured":"Vallg\u00e5rda, S. et al. Should Europe follow the US and declare obesity a disease?: A discussion of the so-called utilitarian argument. Eur. J. Clin. Nutr. 71(11), 1263\u20137 (2017).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"3","key":"53073_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S2213-8587(17)30292-9","volume":"6","author":"N Stefan","year":"2018","unstructured":"Stefan, N., H\u00e4ring, H. U. & Schulze, M. B. Metabolically healthy obesity: The low-hanging fruit in obesity treatment?. Lancet Diabetes Endocrinol. 6(3), 249\u201358 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"53073_CR16","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1172\/JCI129186","volume":"129","author":"GI Smith","year":"2019","unstructured":"Smith, G. I., Mittendorfer, B. & Klein, S. Metabolically healthy obesity: Facts and fantasies. J. Clin. Invest. 129(10), 3978\u201389 (2019).","journal-title":"J. Clin. Invest."},{"issue":"11","key":"53073_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41574-024-01008-5","volume":"20","author":"MB Schulze","year":"2024","unstructured":"Schulze, M. B. & Stefan, N. Metabolically healthy obesity: From epidemiology and mechanisms to clinical implications. Nat. Rev. Endocrinol. 20(11), 633\u201346 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"53073_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1590\/2359-3997000000232","volume":"60","author":"EB Parente","year":"2016","unstructured":"Parente, E. B. Is body mass index still a good tool for obesity evaluation?. Arq. Bras. Endocrinol. Metabol. 60(6), 507\u2013509 (2016).","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"4","key":"53073_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1370\/afm.240330","volume":"23","author":"AG Mainous","year":"2025","unstructured":"Mainous, A. G. et al. Body Mass Index vs Body Fat Percentage as a Predictor of Mortality in Adults Aged 20\u201349 Years. Ann. Fam Med. 23 (4), 337\u2013343 (2025).","journal-title":"Ann. Fam Med."},{"issue":"1","key":"53073_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7570\/jomes21011","volume":"30","author":"HS Kim","year":"2021","unstructured":"Kim, H. S. & Jung, C. H. Metabolically healthy obesity: Is it really a benign condition?. J. Obes. Metab. Syndr. 30(1), 1\u20133 (2021).","journal-title":"J. Obes. Metab. Syndr."},{"key":"53073_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.metabol.2019.01.003","volume":"93","author":"M Kouvari","year":"2019","unstructured":"Kouvari, M. et al. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study. Metabolism 93, 18\u201324 (2019).","journal-title":"Metabolism"},{"issue":"3","key":"53073_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3803\/EnM.2020.301","volume":"35","author":"N Stefan","year":"2020","unstructured":"Stefan, N. Metabolically healthy and unhealthy normal weight and obesity. Endocrinol. Metab. 35(3), 487\u2013493 (2020).","journal-title":"Endocrinol. Metab."},{"issue":"7","key":"53073_CR23","doi-asserted-by":"publisher","first-page":"e183788","DOI":"10.1001\/jamanetworkopen.2018.3788","volume":"1","author":"H Riaz","year":"2018","unstructured":"Riaz, H. et al. Association between obesity and cardiovascular outcomes: A systematic review and meta-analysis of Mendelian randomization studies. JAMA Netw. Open. 1(7), e183788 (2018).","journal-title":"JAMA Netw. Open."},{"issue":"9","key":"53073_CR24","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s41366-022-01165-5","volume":"46","author":"A Jayedi","year":"2022","unstructured":"Jayedi, A., Khan, T. A., Aune, D., Emadi, A. & Shab-Bidar, S. Body fat and risk of all-cause mortality: A systematic review and dose-response meta-analysis of prospective cohort studies. Int J Obes (Lond) 46(9), 1573\u201381 (2022).","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"53073_CR25","first-page":"139","volume":"6","author":"GA Gellert","year":"2025","unstructured":"Gellert, G. A. et al. Comorbidities, and Care-Seeking Intent Among Individuals with Obesity or Overweight Status Using Outpatient AI-Based Virtual Triage. Telemed Rep. 6 (1), 139\u2013147 (2025).","journal-title":"Telemed Rep."},{"key":"53073_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.857930","volume":"13","author":"N Mohammadian Khonsari","year":"2022","unstructured":"Mohammadian Khonsari, N. et al. Normal weight obesity and cardiometabolic risk factors: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 13, 857930 (2022).","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"53073_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12916-024-03588-5","volume":"22","author":"L Heath","year":"2024","unstructured":"Heath, L. et al. Strategies to improve the implementation of preventive care in primary care: A systematic review and meta-analysis. BMC Med. 22(1), 412 (2024).","journal-title":"BMC Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53073-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:40:35Z","timestamp":1785886835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53073-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53073"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53073-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted on the database obtained from the Three Generations for Health Program, which is a national prevention program in Hungary based on Government Decision No.1234\/2017 (IV. 28.). Gottsegen National Cardiovascular Center is responsible for providing professional, organizational, and IT support for the participating general practices\/clusters and for scientific monitoring of the program. Gottsegen National Cardiovascular Center is the data controller of the program; therefore; there was no need for any administrative permissions to access the raw data used in our study. Regarding the approval, the Medical Research Council deemed that ethical approval was not necessary. Their decision was made because the research was conducted using data extracted from a program that was based on Government Decision No.1234\/2017 (IV. 28.), which is exempt from requiring compulsory ethical approval. All methods were performed in accordance with relevant guidelines and regulations and the Declaration of Helsinki. Informed consent was obtained from all subjects participating in the Three Generations for Health Program.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24105"}}